NIHR Maudsley BRC Blog

Our latest news and events

New funding for innovative neuroimaging research

The NIHR Maudsley BRC has launched two new funding opportunities to support neuroimaging research to investigate the impact of COVID-19 on underrepresented groups and to apply novel analytical methods to existing neuroimaging data.

By NIHR Maudsley BRC at 3 Aug 2021
Read more >

COVID-19 variant vaccine begins recruiting in south London

Volunteers in south London are being asked to take part in a study using an Oxford/AstraZeneca variant vaccine, aimed at preventing the Beta COVID-19 variant.

By NIHR Wellcome King's Clinical Research Facility at 7 Jul 2021
Read more >

New research from King's has identified three key inflammatory proteins which are lower in individuals at risk of severe COVID-19.

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, and Weill Cornell Medicine, New York City, has identified three key inflammatory proteins which are lower in individuals at risk of severe COVID-19.

By NIHR Maudsley BRC at 8 Jun 2021
Read more >

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR Wellcome King's Clinical Research Facility at 14 Apr 2021
Read more >

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021
Read more >